Katerina Akassoglou is a senior investigator at the Gladstone Institute of Neurological Disease, and a professor in the department of neurology at the University of California, San Francisco. She has pioneered studies in the investigation of vascular and immune mechanisms in neurologic diseases and, in particular, the role of the blood clotting factors in CNS autoimmunity, trauma, and neurodegeneration. Akassoglou has been awarded the Presidential Early Career Award for Scientists and Engineers by the White House, the John J. Abel Award from the American Society of Pharmacology and Experimental Therapeutics, and The Marilyn Hilton Award for Innovation in MS Research by the Conrad N. Hilton Foundation. Akassoglou earned a PhD in neurobiology at the University of Athens, Greece. She was trained in neuropathology at the University of Vienna before performing her postdoctoral work at the State University of New York at Stony Brook, Rockefeller University, and New York University.